The Pathogenesis, Assessment and Treatment of Speech Fluency Disorders

Neumann, Katrin; Euler, Harald Α.; Bosshardt, Hans-Georg; Cook, Susanne; Sandrieser, Patricia; Sommer, Martin

doi:10.3238/arztebl.2017.0383

Cited by 16 publications

(25 citation statements)

References 98 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The current research makes a valuable contribution to the field by identifying and attempting to address limitations in these previous reviews of interventions for adults who stutter. First, some reviews had date restrictions in study inclusion criteria, such as only including studies from 1990 to 2014 11 or from 2000 to 2016 69 . The current review's inclusion of studies from journal inception allowed for the synthesis to capture a wider range of interventions, particularly psychological therapies used in the 1970s and 1980s that may continue to be effective for some adults who stutter today.…”

Section: Discussionmentioning

confidence: 99%

“…Some reviews have made conclusions on specific intervention approaches that are most effective for adults who stutter and include speech restructuring, 69 and a combined treatment approach including prolonged speech and self‐management 12 . Such conclusions should be interpreted in the context of limitations of the reviews including high risk of study bias 12 and a lack of reporting of quality appraisal results 69 . In addition, such results are challenged by a recent qualitative synthesis by Johnson et al 70 which explored adults’ experiences and perspectives of stuttering therapy.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Effectiveness of nonpharmacological stuttering interventions on communication and psychosocial functioning in adults: A systematic review and meta‐analysis of randomized controlled trials

Connery

Galvin

McCurtin

2020

J Evidence Based Medicine

View full text Add to dashboard Cite

Objective To conduct a systematic review and meta‐analysis of the research evidence examining the effectiveness of nonpharmacological stuttering therapy on communication and psychosocial functioning for adults who stutter. Methods A systematic search of nine electronic databases for studies published from database inception to December 2018 was completed to identify randomized controlled trials of interventions for adults with developmental stuttering. Two reviewers independently screened articles and assessed methodological quality using the Cochrane risk‐of‐bias tool. Treatment outcomes were classified using the International Classification of Functioning, Disability and Health (ICF) framework. Results The search yielded nine randomized controlled trials, comprising 276 participants, using a diverse range of interventions which were classified into four categories: speech restructuring interventions; speech restructuring plus psychological interventions; interventions with stimulating techniques and interventions targeting anxiety. Meta‐analysis showed that interventions did not demonstrate a significant pooled difference when compared to comparison groups in improving speech fluency (standardized mean difference [SMD] = –0.35, 95% confidence interval [CI] –1.14 to 0.45, I2 = 81%, P = .39), overall experience of stuttering (mean difference [MD] = –0.10, 95% CI –0.36 to 0.15, I2 = 0%, P = .43) and quality of life (SMD = –0.32, 95% CI –0.83 to 0.19, I2 = 0%, P = .21). Conclusions This article identified a diverse range of treatments and outcome measures for adults who stutter, with meta‐analysis highlighting no significant pooled difference between intervention and comparator groups in improving communication and psychosocial functioning.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Effectiveness of nonpharmacological stuttering interventions on communication and psychosocial functioning in adults: A systematic review and meta‐analysis of randomized controlled trials

Connery

Galvin

McCurtin

2020

J Evidence Based Medicine

View full text Add to dashboard Cite

show abstract

“…Even with normal dysfluency or mild stuttering, patients and families may benefit from referral to a fluency subspecialist or speech-language pathologist for additional support and acknowledgment of individual concerns. [14]…”

Section: Assessmentmentioning

confidence: 99%

Management of stuttering using cognitive behavior therapy and mindfulness meditation

et al. 2019

View full text Add to dashboard Cite

Stuttering is a speech fluency disorder with varied etiological explanations. It is important to identify symptoms early so that adequate and timely intervention can be delivered with focus on management and recovery. Stuttering, besides affecting speech fluency, might have a number of negative psychosocial consequences for the sufferer that may lead to immense anxiety, besides other symptoms. Therefore, it is thus imperative to include multiple dimensions in the holistic treatment of stuttering. Cognitive behavior therapy and mindfulness equip the client with the skills to manage the problems that occur as a result of stuttering. Since the rate of relapse in this condition is high, the chosen therapeutic paradigm must involve booster sessions over a long term. Periodic, detailed assessment would update the therapist about the barriers in treatment and would help in devising appropriate methods to get rid of these hindrances.

show abstract

“…In dialogue with therapists, and during the creation of the guidelines for speech fluency disorders (Neumann et al, 2017), the scarcity of data regarding the current state of stuttering therapy in Germany was emphasized (Radtke, 2019;Waltersbacher, 2019). Questions regarding (1) the frequency with which stuttering is diagnosed in Germany and (2) the form, intensity, and duration of current stuttering therapies in Germany were raised.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data

Sommer

Waltersbacher

Schlotmann

et al. 2021

Front. Hum. Neurosci.

Self Cite

View full text Add to dashboard Cite

PurposeTo evaluate the prevalence and treatment patterns of speech and language disorders in Germany.MethodsA retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification (ICD-10 GM) codes for stuttering (F98.5), cluttering (F98.6), and developmental disorders of speech and language (F80) to identify prevalent and newly diagnosed cases each year. Prescription and speech therapy reimbursement data were used to evaluate treatment patterns.ResultsIn 2017, 27,977 patients of all ages were diagnosed with stuttering (21,045 males, 75% and 6,932 females, 25%). Stuttering prevalence peaks at age 5 years (boys, 0.89% and girls, 0.40%). Cluttering was diagnosed in 1,800 patients of all ages (1,287 males, 71.5% and 513 females, 28.5%). Developmental disorders of speech and language were identified in 555,774 AOK-insurants (61.2% males and 38.8% females). Treatment data indicate a substantial proportion newly diagnosed stuttering individuals receive treatment (up to 45% of 6-year-old patients), with slightly fewer than 20 sessions per year, on average. We confirmed a previous study showing increased rates of atopic disorders and neurological and psychiatric comorbidities in individuals with stuttering, cluttering, and developmental disorders of speech and language.ConclusionThis is the first nationwide study using health insurance data to analyze the prevalence and newly diagnosed cases of a speech and language disorder. Prevalence and gender ratio data were consistent with the international literature. The crude prevalence of developmental disorders of speech and language increased from 2015 to 2018, whereas the crude prevalence for stuttering remained stable. For cluttering, the numbers were too low to draw reliable conclusions. Proportional treatment allocation for stuttering peaked at 6 years of age, which is the school entrance year, and is later than the prevalence peak of stuttering.

show abstract

The Pathogenesis, Assessment and Treatment of Speech Fluency Disorders

Abstract: SUMMARYBackground: Approximately 1% of children and adolescents, 0.2% of women, and 0.8% of men suffer from stuttering, and lesser numbers from cluttering. Persistent speech fluency disorders often cause lifelong problems in communication and social participation.

Cited by 16 publications

References 98 publications

Effectiveness of nonpharmacological stuttering interventions on communication and psychosocial functioning in adults: A systematic review and meta‐analysis of randomized controlled trials

Effectiveness of nonpharmacological stuttering interventions on communication and psychosocial functioning in adults: A systematic review and meta‐analysis of randomized controlled trials

Management of stuttering using cognitive behavior therapy and mindfulness meditation

Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data

Contact Info

Product

Resources

About